MediFind
Condition

Membranous Nephropathy

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Idiopathic Membranous Nephropathy
  • Journal: Medical archives (Sarajevo, Bosnia and Herzegovina)
  • Treatment Used: Immunosuppressive Drugs
  • Number of Patients: 1
  • Published —
The study researched the treatment of idiopathic membranous nephropathy.
Latest Advance
Study
  • Condition: Primary Membranous Nephropathy
  • Journal: The American journal of case reports
  • Treatment Used: Intravitreal Bevacizumab
  • Number of Patients: 1
  • Published —
The study researched the outcomes of a case of primary membranous nephropathy.
Latest Advance
Study
  • Condition: Cancer
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Immune Checkpoint Inhibitor Therapy
  • Number of Patients: 309
  • Published —
The study researched the safety of immune checkpoint inhibitor therapy.
Latest Advance
Study
  • Condition: Pregnant Woman with Primary Membranous Nephropathy
  • Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
  • Treatment Used: Immunosuppressive treatment with Prednisone, Cyclosporine A, and Enoxaparine
  • Number of Patients: 1
  • Published —
This case report described a 21-year old pregnant female diagnosed with primary membranous nephropathy treated with immunosuppressive treatment consisting of prednisone, cyclosporine A, and enoxaparine.
Latest Advance
Study
  • Condition: Idiopathic Membranous Nephropathy (IMN)
  • Journal: Medicine
  • Treatment Used: Total Triiodothyronine (TT3) Reduction
  • Number of Patients: 121
  • Published —
This study investigated the effect of total triiodothyronine (TT3) reduction in the follow-up of patients with idiopathic membranous nephropathy (IMN).
Latest Advance
Study
  • Condition: Multirelapsing Membranous Nephropathy
  • Journal: BMJ case reports
  • Treatment Used: Ofatumumab
  • Number of Patients: 1
  • Published —
This case evaluated the treatment of multirelapsing membranous nephropathy with ofatumumab.
Latest Advance
Study
  • Condition: Idiopathic Membranous Nephropathy
  • Journal: Medical science monitor : international medical journal of experimental and clinical research
  • Treatment Used: Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody
  • Number of Patients: 72
  • Published —
This study tested the safety and efficacy of using an anti-PLA2R antibody to treat patients with idiopathic membranous nephropathy.
Latest Advance
Study
  • Condition: Membranous Nephropathy
  • Journal: Medicine
  • Treatment Used: Wuzhi Soft Capsule (WZC)
  • Number of Patients: 75
  • Published —
This study investigated the correlation between the effect of Wuzhi soft capsule (WZC) on FK506 concentration and CYP3A5 gene polymorphism in patients with membranous nephropathy (MN).
Latest Advance
Study
  • Condition: Syphilis-Associated Acute Renal Failure and Hepatitis in the Setting of Human Immunodeficiency Virus Coinfection
  • Journal: Sexually transmitted diseases
  • Treatment Used: Penicillin
  • Number of Patients: 2
  • Published —
This case report discusses patients with human immunodeficiency virus who presented in acute renal (kidney) failure with nephrotic range proteinuria and were diagnosed with secondary syphilis.
Latest Advance
Study
  • Condition: Immune-Mediated Disorders
  • Journal: Frontiers in immunology
  • Treatment Used: Rituximab
  • Number of Patients: 0
  • Published —
This study investigated the safety and efficacy of using rituximab to treat various immune-mediated disorders.
Latest Advance
Study
  • Condition: Idiopathic membranous nephropathy in adults with nephrotic syndrome
  • Journal: BMJ open
  • Treatment Used: Immunosuppressive agents
  • Number of Patients: 2736
  • Published —
The study compared different immunosuppressive agents (inhibit the activity of the immune system) in treating idiopathic membranous nephropathy in adults with nephrotic syndrome.
Latest Advance
Study
  • Condition: Membranous nephropathy
  • Journal: PloS one
  • Treatment Used: Phospholipase A2 receptor 1 antibody
  • Number of Patients: 243
  • Published —
The study used the Phospholipase A2 receptor 1 antibody levels at time of diagnosis in patients with membranous nephropathy to determine the long-term kidney outcomes.